Sign in

CIK 0001430306

  • Non-accelerated filer
  • Smaller reporting company

Tonix Pharmaceuticals Holding Corp.

Sign in to watch
Ticker
TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
261434750
Phone
+1 212-980-9155
Business address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Former names
TAMANDARE EXPLORATIONS INC.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4/A Open-market buy Chief Medical Officer bought 5,000 shares at $5.18 ($25,900)
  10. 4/A Open-market buy Chief Medical Officer bought 4,694 shares at $5.95 ($27,925)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy Chief Medical Officer bought 5,000 shares at $5.18 ($25,900)
  13. 4 Open-market buy Chief Financial Officer bought 400 shares at $5.83 ($2,330)
  14. 4 Open-market buy Chief Medical Officer bought 4,694 shares at $5.95 ($27,925)
  15. 4 Open-market buy Chief Executive Officer bought 6,000 shares at $6.50 ($39,000)
  16. 4 Open-market buy Director bought 10,000 shares at $6.05 ($60,500)
  17. 4 Open-market buy Director bought 1,468 shares at $6.40 ($9,395)
  18. 4 Open-market buy Director bought 2,532 shares at $6.20 ($15,698)
  19. 4 Open-market buy Director bought 6,000 shares at $6.64 ($39,867)
  20. 4 Open-market buy Director bought 15,000 shares at $6.93 ($104,018)

Page 13 of 19 · 376 filings